- £4.39bn
- £5.08bn
- £1.67bn
- 96
- 27
- 12
- 37
Annual income statement for Spirax, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,193 | 1,345 | 1,611 | 1,683 | 1,665 |
| Cost of Revenue | |||||
| Gross Profit | 905 | 1,040 | 1,229 | 1,281 | 1,269 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 944 | 1,024 | 1,292 | 1,398 | 1,361 |
| Operating Profit | 249 | 321 | 319 | 284 | 305 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 240 | 315 | 308 | 245 | 259 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 174 | 235 | 225 | 184 | 191 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 174 | 235 | 225 | 184 | 191 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 174 | 235 | 225 | 184 | 191 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.35 | 3.2 | 3.63 | 3.11 | 2.6 |
| Dividends per Share |